Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (9): 822-827.DOI: 10.3969/j.issn.1673-8640.2017.09.017
• Orginal Article • Previous Articles Next Articles
GONG Xiaolin
Received:
2017-05-18
Online:
2017-09-30
Published:
2017-09-30
CLC Number:
GONG Xiaolin. Role of substrate depletion limit parameters in BS-2000M2 automatic chemistry analysis system[J]. Laboratory Medicine, 2017, 32(9): 822-827.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.09.017
项目 | 试剂盒线性 范围上限 | 底物耗尽 可报告范围上限 | 临床最高 可见浓度 | 样本例数 (例) | 在底物耗尽可报告范围内的样本比例(%) |
---|---|---|---|---|---|
ALT(U/L) | 1 000 | 3 339 | 1 232 | 63 946 | 100.00 |
AST(U/L) | 800 | 7 411 | 4 708 | 45 245 | 100.00 |
ALP(U/L) | 800 | 3 407 | 2 338 | 42 387 | 100.00 |
GGT(U/L) | 650 | 3 945 | 3 464 | 42 326 | 100.00 |
LDH(U/L) | 1 000 | 7 646 | 6 877 | 21 161 | 100.00 |
α-HBDH(U/L) | 1 000 | 9 783 | 4 829 | 19 497 | 100.00 |
CK(U/L) | 1 000 | 14 106 | 30 764 | 11 097 | 99.96 |
CK-MB(U/L) | 600 | 3 296 | 1 299 | 8 877 | 100.00 |
α-AMY(U/L) | 1 500 | 9 700 | 3 463 | 8 126 | 100.00 |
尿素(mmol/L) | 40 | 54 | 139 | 45 963 | 99.97 |
项目 | 试剂盒线性 范围上限 | 底物耗尽 可报告范围上限 | 临床最高 可见浓度 | 样本例数 (例) | 在底物耗尽可报告范围内的样本比例(%) |
---|---|---|---|---|---|
ALT(U/L) | 1 000 | 3 339 | 1 232 | 63 946 | 100.00 |
AST(U/L) | 800 | 7 411 | 4 708 | 45 245 | 100.00 |
ALP(U/L) | 800 | 3 407 | 2 338 | 42 387 | 100.00 |
GGT(U/L) | 650 | 3 945 | 3 464 | 42 326 | 100.00 |
LDH(U/L) | 1 000 | 7 646 | 6 877 | 21 161 | 100.00 |
α-HBDH(U/L) | 1 000 | 9 783 | 4 829 | 19 497 | 100.00 |
CK(U/L) | 1 000 | 14 106 | 30 764 | 11 097 | 99.96 |
CK-MB(U/L) | 600 | 3 296 | 1 299 | 8 877 | 100.00 |
α-AMY(U/L) | 1 500 | 9 700 | 3 463 | 8 126 | 100.00 |
尿素(mmol/L) | 40 | 54 | 139 | 45 963 | 99.97 |
[1] | 周新,府伟灵. 临床生物化学与检验[M]. 北京:人民卫生出版社,2008:98-100. |
[2] | 卫生部临床检验标准专业委员会. WS/T403—2012 临床生物化学检验常规项目分析质量指标[S]. 北京:中国标准出版社,2012. |
[3] | 田洪伦,尹科,何军,等. 东芝TBA-120FR全自动生化分析仪FLEX模式在高浓度酶样本检测中的应用[J]. 检验医学,2016,31(8):684-687. |
[4] | 宋云霄,张海晨,袁文华,等. 读点前移模式在拜耳ADVIA 1650全自动生化分析仪上的特点评价及临床应用[J]. 检验医学,2010,25(1):1-3. |
[5] | Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement methods[S]. EP5-A3,CLSI,2015. |
[6] | Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures:a statistical approach[S]. EP6-A,CLSI,2003. |
[7] | Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry[S]. EP7-A2,CLSI,2005. |
[8] | Clinical and Laboratory Standards Institute. Measurement procedure comparison and bias estimation using patient samples[S]. EP9-A3,CLSI,2013. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||